Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6291210

Title:Differentiation inhibitor
Inventors:Sakano, Seiji; Shizuoka, Japan
Itoh, Akira; Shizuoka, Japan
Summary:This invention introduces human serrate-2 gene expression products, methods and uses thereof. Described herein is a novel human serrate-2 polypeptide consisting of a polypeptide capable of regulating the differentiation of undifferentiated cells from stem cells. Specific amino acid sequences are provided, as are genetic properties as well as the antibodies specifically recognizing the polypeptide, and methods of their production. Therapeutic applications include the regulation of stem cell differentiation in the treatment of a variety of neoplasms, such as leukemia.
Abstract:A novel human serrate-2 polypeptide consisting of a polypeptide containing the amino acid sequence described in SEQ ID NO: 1 in the Sequence Listing and having the effect of regulating the differentiation of undifferentiated cells involving stem cells; its gene; a process for producing the same; and an antibody specifically recognizing the polypeptide.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6291210
Application Number:US1999000214278
Date Filed:26/01/1999
Date Published:18/09/2001
Assignee:Asahi Kasei Kabushiki Kaisha, Osaka, Japan


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021